Valuation check: SNY's profit margin is 11.18%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), SNY shows a profit margin of 11.18%. That compares with 21.16% in the prior-year period — down 47.1% year over year. That is below the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNY's profit margin is now 11.18% (was 21.16%) — a 47.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sanofi is outperforming or lagging.
The Healthcare sector average profit margin is about 14.34%. Sanofi is at 11.18%, which is lower that average. That is roughly 22.0% below the sector mean. Use the comparison chart on this page to see how SNY stacks up against individual peers as well.
That compares with 21.16% in the prior-year period — down 47.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sanofi with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Sanofi's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 11.18%) with ownership activity and broader fundamentals.